Search Results - Yufan Huang

Cost-effectiveness analysis of zolbetuximab plus mFOLFOX6 as the first-line treatment for CLDN18.2-positive, HER2-negative advanced gastric or Gastroesophageal Adenocarcinoma by Yufan Huang, Maojin You, Qundan Wu, Ruijia Chen

Connect to this object online.

Global, regional, and national burden of age-related macular degeneration, 1990-2019: an age-period-cohort analysis based on the Global Burden of Disease 2019 Study by Yufan Huang, Tong Tang, Dongyue Wang, Yunxia Gao, Ming Zhang

Connect to this object online.

Cost-effectiveness analysis of adebrelimab combined with chemotherapy for extensive-stage small cell lung cancer by Maojin You, Ruijia Chen, Qingfeng Wu, Wei Zhu, Ying He, Yufan Huang

Connect to this object online.

The cost-effectiveness of cemiplimab plus chemotherapy as the first-line treatment for advanced non-small cell lung cancer by Tingting Lu, Yufan Huang, Zhongjie Cai, Wangchun Lin, Xiaoxiao Chen, Ruijia Chen, Yingying Hu

Connect to this object online.

Cost-effectiveness analysis of transarterial chemoembolization combined with lenvatinib as the first-line treatment for advanced hepatocellular carcinoma by Ying He, Wangchun Lin, Zhongjie Cai, Yufan Huang, Maojin You, Meisheng Lei, Ruijia Chen

Connect to this object online.